Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Natural Killer Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02420873
What this trial is testing

An Open-label Phase II Study of Lorvotuzumab Mertansine

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 9
Early research (Phase 1)UnknownNCT06367673
What this trial is testing

Natural Killer(NK) Cell Therapy Targeting CLL1 or CD33 in Acute Myeloid Leukemia

Who this might be right for
AML, Adult
Zhejiang University 24
Early research (Phase 1)Looking for participantsNCT07011004
What this trial is testing

Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia

Who this might be right for
Acute Myeloid Leukemia RefractoryAcute Myeloid Leukemia, in Relapse
Memorial Sloan Kettering Cancer Center 18
Not applicableStudy completedNCT02301065
What this trial is testing

Analysis of T Cell and Natural Killer (NK) Cell in Relation to Viral Infections in Pediatric Stem Cell Transplant Patients and Donors

Who this might be right for
Hematologic Malignancies
St. Jude Children's Research Hospital 35
Testing effectiveness (Phase 2)UnknownNCT01898663
What this trial is testing

DCs Vaccine Combined With Cytokine-induced Killer Cells in Patients With AML

Who this might be right for
High-risk Soft Tissue Sarcoma
Affiliated Hospital to Academy of Military Medical Sciences 30
Not applicableStudy completedNCT06320392
What this trial is testing

Implication of CCR4-NOT Complex Subunit 7 Expression in Natural Killer Cell Resistance in Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Ain Shams University 90
Testing effectiveness (Phase 2)Study completedNCT01807611
What this trial is testing

Haploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic Malignancy

Who this might be right for
LeukemiaLymphoma
St. Jude Children's Research Hospital 82
Early research (Phase 1)Looking for participantsNCT06793956
What this trial is testing

Sintilimab and Linperlisib Combination Treatment in Relapsed or Refractory Extranodal Natural Killer/T Cell Lymphoma

Who this might be right for
Extranodal Natural Killer/T Cell Lymphoma
Sun Yat-sen University 12
Not applicableActive Not RecruitingNCT03761875
What this trial is testing

NK Cell Deregulation in HBV Patients

Who this might be right for
Hepatitis B Virus
University Hospital, Limoges 80
Testing effectiveness (Phase 2)Study completedNCT04004572
What this trial is testing

Sintilimab, Pegaspargase and Anlotinib for Stage IV Natural Killer /T-cell Lymphoma

Who this might be right for
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
Rong Tao 37
Testing effectiveness (Phase 2)Study completedNCT00283985
What this trial is testing

Association of L-asparaginase-Methotrexate-Dexamethasone for Nasal and Nasal-type Natural Killer (NK)-T-cell Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin
University Hospital, Limoges 40
Not applicableStudy completedNCT02565589
What this trial is testing

Hyporesponsiveness of Natural Killer Cells and a Dysfunctional Inflammatory Response in Critically Ill Patients

Who this might be right for
Critical Illness
Yonsei University 48
Not applicableNot Yet RecruitingNCT07542912
What this trial is testing

Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma

Who this might be right for
Complete Remission Rate， CRRProgression Free SurvivalOverall Survival+2 more
Sun Yat-sen University 30
Early research (Phase 1)Study completedNCT00089453
What this trial is testing

Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma
University of Arkansas 10
Not applicableUnknownNCT04214730
What this trial is testing

Study of NK Combined With Chemotherapy for Advanced Solid Tumor

Who this might be right for
Solid Tumor
Yantai Yuhuangding Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT04329728
What this trial is testing

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Who this might be right for
Lymphoid Malignancies
AVM Biotechnology Inc 144
Testing effectiveness (Phase 2)Study completedNCT01390402
What this trial is testing

Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG

Who this might be right for
LeukemiaChronic Myelogenous Leukemia
M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)UnknownNCT01821482
What this trial is testing

DC-CIK to Treat Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Guangxi Medical University 100
Early research (Phase 1)Ended earlyNCT04489420
What this trial is testing

Natural Killer Cell (CYNK-001) IV Infusion or IT Administration in Adults With Recurrent GBM

Who this might be right for
Astrocytoma, Grade IVGiant Cell GlioblastomaGlioblastoma Multiforme+11 more
Celularity Incorporated 3
Testing effectiveness (Phase 2)Study completedNCT05040438
What this trial is testing

Natural Killer (NK) Cell Therapy in Locally Advanced HCC

Who this might be right for
Locally Advanced Hepatocellular Carcinoma
Vaxcell Bio, Co., Ltd. 17
Next Page